The goal of this activity is to adequately prepare clinicians from all specialties who encounter patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/MASH to be able to effectively and confidently implement rapidly evolving strategies to identify at-risk patients, risk stratify, and treat patients using the most current evidence-based recommendations. In addition, this initiative aims to increase knowledge among patients regarding fatty liver disease and prepare them to talk to their doctor and healthcare team about ways to help manage fatty liver disease.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1000589
- Start Date: 2024-04-10 05:00:00
- End Date: 2024-04-10 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Madrigal Pharmaceutics - Amount: 50052.0 - Is Kind Support: False
- Activity Type: Other/Blended Learning
- CME Finder Type: Other
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest